{
    "clinical_study": {
        "@rank": "167979", 
        "arm_group": {
            "arm_group_label": "Testosterone gel (FE 999303)", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a Phase 3 clinical trial in adult hypogonadal males with baseline serum testosterone\n      concentrations <300 ng/dL. The purpose of this study is to evaluate the safety and efficacy\n      of testosterone gel delivered using an applicator."
        }, 
        "brief_title": "A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Adult Male Hypogonadism", 
        "condition_browse": {
            "mesh_term": [
                "Hypogonadism", 
                "Eunuchism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Males between 18-75 years of age\n\n          2. Two screening serum testosterone values less than 300ng/dL\n\n          3. One or more symptoms of testosterone deficiency\n\n        Exclusion Criteria:\n\n          1. Previous use of the investigational product\n\n          2. Use of any investigational product within 30 days prior to screening and during the\n             study\n\n          3. BMI less than 18kg/m2 or more than 35kg/m2\n\n          4. Prostatic mass(es)\n\n          5. Generalized skin irritation or skin disease\n\n          6. Lower urinary tract obstruction\n\n          7. Myocardial infarction or cerebrovascular accident in the last 6 months\n\n          8. Unstable angina or congestive heart failure\n\n          9. Tromboembolic disorders\n\n         10. Sleep apnea\n\n         11. Hyperparathyroidism or uncontrolled diabetes\n\n         12. Untreated moderate to severe depression\n\n         13. History of testicular, prostate, or breast cancer\n\n         14. HIV, Hepatitis B, or Hepatitis C positive\n\n         15. PSA more or equal to 3 ng/mL\n\n         16. Use of any medications that could be considered anabolic\n\n         17. Use of estrogens, Gonadotropin Releasing Hormone agonists/antagonists, antiandrogens,\n             or human Growth Hormone\n\n         18. Chronic use of any drug of abuse\n\n         19. Involvement in a sport in which there is a screening for anabolic steroids\n\n         20. Not willing to use adequate contraception during the study\n\n         21. Partner is pregnant and/or breast feeding\n\n         22. Partner has a history of breast, uterine or ovarian cancer"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01665599", 
            "org_study_id": "000023"
        }, 
        "intervention": {
            "arm_group_label": "Testosterone gel (FE 999303)", 
            "description": "The testosterone gel is delivered using an applicator", 
            "intervention_name": "Testosterone gel (FE 999303)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Testosterone", 
                "Testosterone enanthate", 
                "Testosterone undecanoate", 
                "Testosterone 17 beta-cypionate", 
                "Methyltestosterone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 8, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "Medical Affiliated Research Cente"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "California Professional Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "San Diego Sexual Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlebury", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "Connecticut Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aventura", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "South Florida Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Clair Shores", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Michigan Institute of Urology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska"
                    }, 
                    "name": "Quality Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lawrenceville", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Premier Urology Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "University Urology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poughkeepsie", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Premier Medical Group of the Hudson Valley"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "PMG Research of Wilmington"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Tristate Urologic Services"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warwick", 
                        "country": "United States", 
                        "state": "Rhode Island"
                    }, 
                    "name": "Omega Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Pleasant", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Coastal Carolina Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Myrtle Beach", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Carolina Urologic Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Clinical Research Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Urology Clinics of North Texas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }, 
                    "name": "St. Joseph's Healthcare"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Bay", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }, 
                    "name": "Private Practice and Clinical Research"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 3, Open-label, Non-randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males", 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The percentage of subjects on day 90 whose Cavg (0-24) serum total testosterone levels are between 300 and 1050 ng/dL", 
            "safety_issue": "No", 
            "time_frame": "Day 90"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01665599"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The percentage of subjects on Day 1 whose serum Cavg (0-24) serum total testosterone levels are between 300 and 1050 ng/dL", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Pharmacokinetics of total testosterone measuring AUC\u03c4, Tmax, Cmax, Cave, Cmin, and T1/2", 
                "safety_issue": "No", 
                "time_frame": "Day 1; Day 90"
            }, 
            {
                "measure": "Change from baseline in the international index of erectile dysfunction (IIEF)questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Day 91"
            }, 
            {
                "measure": "Pharmacokinetics of DHT (dihydrotestosterone) measuring AUC\u03c4, Tmax, Cmax, Cave, Cmin, and T1/2", 
                "safety_issue": "No", 
                "time_frame": "Day 1; Day 90"
            }, 
            {
                "measure": "Change from baseline in the multidimensional assessment of fatigue (MAF)questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Day 91"
            }, 
            {
                "measure": "Change from baseline in the SF-12 health questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Day 91"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}